Drugmaker Novo Nordisk plans to ask the U.S. Food and Drug Administration to approve the pills later this year.
That's a notion that has long fueled hope for many of the more than 40% of Americans who are considered obese - and fueled criticism from those who advocate for wider weight acceptance.High-dose oral versions of the medication in the weight-loss drug Wegovy
There have been other weight-loss pills on the market, but none that achieve the substantial reductions seen with injected drugs like Wegovy. People with obesity will be"thrilled" to have an oral option that's as effective, said Dr. Katherine Saunders, clinical professor of medicine at Weill Cornell Health and co-founder of Intellihealth, a weight-loss center.
That's"notably consistent" with the weight loss spurred by weekly shots of the highest dose of Wegovy, the study authors said. But the pills aren't necessarily a better option for the hundreds of thousands of people already taking injectable versions such as Ozempic or Wegovy, said Dr. Fatima Cody Stanford, an obesity medicine expert at Massachusetts General Hospital.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Novo Nordisk says obesity pill leads to 15% weight loss; availability 'to be determined'Drugmaker Novo Nordisk on Sunday said a late-stage trial found that a high-dose oral version of its drug semaglutide helped overweight or obese adults lose 15% of their body weight, which is in line with recent results for other experimental obesity pills.
Baca lebih lajut »
Tesla stock slips on downgrade, IBM shares ease on reported deal and other stocks on the moveIBM, Tesla and Novo Nordisk are some of the stocks on the move.
Baca lebih lajut »
No more needles? A daily pill may work as well as Wegovy shots to treat obesityLosing significant amounts of weight may soon be as easy as taking a daily pill. New research released Sunday shows high-dose oral versions of the medication in the blockbuster drugs Ozepmic and Wegovy may work as well as the popular injections — even in hard-to-treat people with diabetes. Drugmaker Novo Nordisk said it intends to seek approval for a weight-loss pill in the U.S. later this year. The company didn't say how much the new pills would cost or how widely available they'll be.
Baca lebih lajut »
Florida man faces felony charges following a high-speed chase through Elmhurst June 22.Bond was set at $100,000 for a Florida man arrested by Elmhurst police Thursday following a high-speed chase that looped along Route 83 from North Avenue south to 16th Street and back.
Baca lebih lajut »
How New York City's sky-high cost of living stacks up to LondonNew York and London are incredibly similar when it comes to lifestyle and cost of living, but London is slightly more affordable across the board.
Baca lebih lajut »
High interest rates and economic uncertainty are behind recent rise in corporate defaultsThe corporate default rate is up and rising as interest rates remain elevated, making it more expensive for companies to refinance debt.
Baca lebih lajut »